Related references
Note: Only part of the references are listed.Opposing activities of IFITM proteins in SARS-CoV-2 infection
Guoli Shi et al.
EMBO JOURNAL (2021)
IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag
Yadvinder S. Ahi et al.
MBIO (2020)
Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state
Kazi Rahman et al.
ELIFE (2020)
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells
Jaewoong Lee et al.
NATURE (2020)
Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptation
Patricia Domingues et al.
NATURE COMMUNICATIONS (2019)
Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1
Romain Appourchaux et al.
JOURNAL OF VIROLOGY (2019)
IFITM3 directly engages and shuttles incoming virus particles to lysosomes
Jennifer S. Spence et al.
NATURE CHEMICAL BIOLOGY (2019)
Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes
Krishna C. Suddala et al.
PLOS PATHOGENS (2019)
The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity
Temet M. McMichael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection
Adrienne G. Randolph et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans
E. Kaitlynn Allen et al.
NATURE MEDICINE (2017)
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
Oliver F. Brandenberg et al.
PLOS PATHOGENS (2017)
Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs
Kevin Tartour et al.
PLOS PATHOGENS (2017)
Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity
Alex A. Compton et al.
EMBO REPORTS (2016)
The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis
Matthew J. Gorman et al.
JOURNAL OF VIROLOGY (2016)
HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolution
Carsten Magnus et al.
VIRUS RESEARCH (2016)
The IFITMs Inhibit Zika Virus Replication
George Savidis et al.
CELL REPORTS (2016)
Bat and pig IFN-induced transmembrane protein 3 restrict cell entry by influenza virus and lyssaviruses
Camilla T. O. Benfield et al.
JOURNAL OF GENERAL VIROLOGY (2015)
IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
Jingyou Yu et al.
CELL REPORTS (2015)
Swine Interferon-Inducible Transmembrane Proteins Potently Inhibit Influenza A Virus Replication
Caroline Lanz et al.
JOURNAL OF VIROLOGY (2015)
Heterosubtypic Antibodies to Influenza A Virus Have Limited Activity against Cell-Bound Virus but Are Not Impaired by Strain-Specific Serum Antibodies
Arkadiusz Wyrzucki et al.
JOURNAL OF VIROLOGY (2015)
IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread
Alex A. Compton et al.
CELL HOST & MICROBE (2014)
Identification of an endocytic signal essential for the antiviral action of IFITM3
Rui Jia et al.
CELLULAR MICROBIOLOGY (2014)
IFITM3 and Susceptibility to Respiratory Viral Infections in the Community
Tara C. Mills et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic Antibody
Arkadiusz Wyrzucki et al.
JOURNAL OF VIROLOGY (2014)
IFITM3 Polymorphism rs12252-C Restricts Influenza A Viruses
David Evan Joseph Williams et al.
PLOS ONE (2014)
Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level
Jason J. Otterstrom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
Kevin Tartour et al.
RETROVIROLOGY (2014)
Chicken Interferon-Inducible Transmembrane Protein 3 Restricts Influenza Viruses and Lyssaviruses In Vitro
S. E. Smith et al.
JOURNAL OF VIROLOGY (2013)
Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3
Linda M. Wakim et al.
NATURE IMMUNOLOGY (2013)
Development of a Neutralization Assay for Influenza Virus Using an Endpoint Assessment Based on Quantitative Reverse-Transcription PCR
Belete Teferedegne et al.
PLOS ONE (2013)
Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals
Yong-Hong Zhang et al.
NATURE COMMUNICATIONS (2013)
Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-Mediated Restriction
Tsai-Yu Lin et al.
CELL REPORTS (2013)
IFITM Proteins Restrict Viral Membrane Hemifusion
Kun Li et al.
PLOS PATHOGENS (2013)
Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates
Tijana Ivanovic et al.
ELIFE (2013)
S-Palmitoylation and Ubiquitination Differentially Regulate Interferon-induced Transmembrane Protein 3 (IFITM3)-mediated Resistance to Influenza Virus
Jacob S. Yount et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular Localization
Rui Jia et al.
JOURNAL OF VIROLOGY (2012)
IFITM3 restricts the morbidity and mortality associated with influenza
Aaron R. Everitt et al.
NATURE (2012)
Ifitm3 Limits the Severity of Acute Influenza in Mice
Charles C. Bailey et al.
PLOS PATHOGENS (2012)
The IFITM Proteins Inhibit HIV-1 Infection
Jennifer Lu et al.
JOURNAL OF VIROLOGY (2011)
IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
Eric M. Feeley et al.
PLOS PATHOGENS (2011)
An enzymatic virus-like particle assay for sensitive detection of virus entry
Donna M. Tscherne et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3
Jacob S. Yount et al.
NATURE CHEMICAL BIOLOGY (2010)
Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines
Balaji Manicassamy et al.
PLOS PATHOGENS (2010)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster
Ulrike C. Lange et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Single-particle kinetics of influenza virus membrane fusion
Daniel L. Floyd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
Pavel Pugach et al.
VIROLOGY (2007)
Characterization of a novel tripartite nuclear localization sequence in the EGFR family
Sheng-Chieh Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Influenza virus pleiomorphy characterized by cryoelectron tomography
Audray Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Kinetics of influenza A virus infection in humans
Prasith Baccam et al.
JOURNAL OF VIROLOGY (2006)
Mechanism of neutralization of influenza virus infectivity by antibodies
M Knossow et al.
VIROLOGY (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
